However, it may be important to reconsider this paradigm in the context of angiogenesis as it has been speculated that NF-κB activation, when performed specifically in endothelial cells, can be an effective anti-angiogenesis therapy in the treatment of cancer [35]. Here, NFKB1 is linked to cancer.